KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 99 filers reported holding KEROS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,489,552 | -18.9% | 360,400 | +2.2% | 3.74% | +10.3% |
| Q2 2023 | $14,169,477 | +39.4% | 352,650 | +48.2% | 3.39% | +11.3% |
| Q1 2023 | $10,162,600 | -11.1% | 238,000 | 0.0% | 3.04% | -23.4% |
| Q4 2022 | $11,428,760 | -5.4% | 238,000 | -25.9% | 3.97% | -20.4% |
| Q3 2022 | $12,087,000 | +58.5% | 321,300 | +16.4% | 4.99% | +45.2% |
| Q2 2022 | $7,626,000 | -47.2% | 276,000 | +3.9% | 3.44% | -23.4% |
| Q1 2022 | $14,451,000 | -7.1% | 265,750 | 0.0% | 4.49% | +36.1% |
| Q4 2021 | $15,549,000 | +11.5% | 265,750 | -24.6% | 3.30% | +26.6% |
| Q3 2021 | $13,945,000 | +39.7% | 352,500 | +50.0% | 2.60% | +57.1% |
| Q2 2021 | $9,980,000 | +3.0% | 235,000 | +49.2% | 1.66% | +16.4% |
| Q1 2021 | $9,694,000 | – | 157,500 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |